Cite
HARVARD Citation
Ando, K. et al. (2020). Higher serum testosterone levels predict poor prognosis in castration‐resistant prostate cancer patients treated with docetaxel. Prostate. 80 (3), pp. 247-255. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ando, K. et al. (2020). Higher serum testosterone levels predict poor prognosis in castration‐resistant prostate cancer patients treated with docetaxel. Prostate. 80 (3), pp. 247-255. [Online].